Ashwini Malla
Overview
Explore the profile of Ashwini Malla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vitayathikornnasak S, Rattanapisit K, Malla A, Suwanchaikasem P, Strasser R, Khorattanakulchai N, et al.
Biotechnol Rep (Amst)
. 2024 May;
42:e00841.
PMID: 38707206
Cobra () venom contains many toxins including α-neurotoxin (αNTX) and phospholipase A2 (PLA2), which can cause neurodegeneration, respiratory failure, and even death. The traditional antivenom derived from animal serum faces...
2.
Kaewbandit N, Malla A, Boonyayothin W, Rattanapisit K, Phetphoung T, Pisuttinusart N, et al.
Sci Rep
. 2023 Aug;
13(1):14160.
PMID: 37644106
No abstract available.
3.
Kaewbandit N, Malla A, Boonyayothin W, Rattanapisit K, Phetphoung T, Pisuttinusart N, et al.
Sci Rep
. 2023 Jul;
13(1):11927.
PMID: 37488213
As a response to invasion by pathogens, the secretion of interleukin 6 (IL-6) which is a cytokine, activates IL-6/JAKs/STAT3 intracellular signaling via., phosphorylation. Over expression of pSTAT3 induces IL-6 positive...
4.
Bulaon C, Sun H, Malla A, Phoolcharoen W
Biotechnol Rep (Amst)
. 2023 Apr;
38:e00794.
PMID: 37064962
The therapeutic blockade of inhibitory PD-1 signaling has emerged as an effective approach for cancer immunotherapy. Nivolumab (Opdivo®), a monoclonal antibody (mAb) targeting the PD-1 immune checkpoint, is approved for...
5.
Shanmugaraj B, Malla A, Bulaon C, Phoolcharoen W, Phoolcharoen N
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560473
Cervical cancer is the most common gynecological malignant tumor worldwide, and it remains a major health problem among women, especially in developing countries. Despite the significant research efforts employed for...
6.
Hanittinan O, Rattanapisit K, Malla A, Tharakhet K, Ketloy C, Prompetchara E, et al.
Front Plant Sci
. 2022 Dec;
13:1012583.
PMID: 36531354
Omalizumab, the anti-immunoglobulin IgE antibody is the only approved and available monoclonal antibody as an auxiliary medicament for the severe respiratory allergic reactions. It forms small size immune complexes by...
7.
Phetphoung T, Malla A, Rattanapisit K, Pisuttinusart N, Damrongyot N, Joyjamras K, et al.
PLoS One
. 2022 Nov;
17(11):e0274737.
PMID: 36367857
Immune checkpoint antibodies in cancer treatment are receptor-ligand pairs that modulate cancer immunity. PD-1/PD-L1 pathway has emerged as one of the major targets in cancer immunotherapy. Atezolizumab, the first anti-PD-L1...
8.
Govea-Alonso D, Malla A, Bolanos-Martinez O, Vimolmangkang S, Rosales-Mendoza S
Pharmaceuticals (Basel)
. 2022 Oct;
15(10).
PMID: 36297410
Despite the current advances in global vaccination against SARS-CoV-2, boosting is still required to sustain immunity in the population, and the induction of sterilizing immunity remains as a pending goal....
9.
Bolanos-Martinez O, Malla A, Rosales-Mendoza S, Vimolmangkang S
Crit Rev Biotechnol
. 2022 Jun;
43(6):823-834.
PMID: 35762029
Cannabis is widely recognized as a medicinal plant owing to bioactive cannabinoids. However, it is still considered a narcotic plant, making it hard to be accessed. Since the biosynthetic pathway...
10.
Shanmugaraj B, Khorattanakulchai N, Panapitakkul C, Malla A, Im-Erbsin R, Inthawong M, et al.
Vaccine
. 2022 Jun;
40(32):4440-4452.
PMID: 35697573
Coronavirus disease 2019 (COVID-19) is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The prevention of SARS-CoV-2 transmission has become a global priority. Previously, we...